T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.18% |
| 2 | Consumer Discretionary | 14.97% |
| 3 | Financials | 14.24% |
| 4 | Technology | 12.89% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
HUB Group
HUBG
$2.46B
| $1.42M | ﹤0.01% |
73,980
| – | – |
|
|
AMJ
1602
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.41M | ﹤0.01% |
44,200
| – | – |
|
1603
New Jersey Resources
NJR
$5.64B
| $1.4M | ﹤0.01% |
36,418
+348
| +1% | +$12.6K |
|
1604
Trinity Industries
TRN
$2.3B
| $1.38M | ﹤0.01% |
103,249
+5,476
| +6% | +$72.4K |
|
|
DWA
1605
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $1.38M | ﹤0.01% |
33,742
+42
| +0.1% | +$1.51K |
|
1606
American Homes 4 Rent
AMH
$12.2B
| $1.38M | ﹤0.01% |
67,149
-2,714
| -4% | -$47K |
|
1607
Idacorp
IDA
$8.16B
| $1.37M | ﹤0.01% |
16,868
+18
| +0.1% | +$1.33K |
|
|
BDN
1608
Brandywine Realty Trust
BDN
$541M
| $1.37M | ﹤0.01% |
81,633
+6,900
| +9% | +$105K |
|
1609
Buckle
BKE
$2.33B
| $1.37M | ﹤0.01% |
52,632
-42,900
| -45% | -$1.16M |
|
|
CST
1610
DELISTED
CST Brands, Inc.
CST
| $1.36M | ﹤0.01% |
31,667
+100
| +0.3% | +$3.96K |
|
|
ISBC
1611
DELISTED
Investors Bancorp, Inc.
ISBC
| $1.36M | ﹤0.01% |
122,926
-16,200
| -12% | -$188K |
|
|
DNY
1612
DELISTED
DONNELLEY R R & SONS CO
DNY
| $1.36M | ﹤0.01% |
80,280
| – | – |
|
1613
Hawaiian Electric Industries
HE
$2.06B
| $1.36M | ﹤0.01% |
41,346
+23
| +0.1% | +$758 |
|
1614
Thor Industries
THO
$4.11B
| $1.35M | ﹤0.01% |
20,848
+360
| +2% | +$23K |
|
1615
NCR Voyix
VYX
$1.17B
| $1.34M | ﹤0.01% |
78,895
+249
| +0.3% | +$4.51K |
|
|
ESV
1616
DELISTED
Ensco Rowan plc
ESV
| $1.33M | ﹤0.01% |
34,221
+20,596
| +151% | +$856K |
|
1617
Cullen/Frost Bankers
CFR
$10.4B
| $1.31M | ﹤0.01% |
20,567
+4,800
| +30% | +$296K |
|
|
VR
1618
DELISTED
Validus Hold Ltd
VR
| $1.3M | ﹤0.01% |
26,840
+3,346
| +14% | +$157K |
|
1619
Kforce
KFRC
$1.03B
| $1.3M | ﹤0.01% |
77,016
| – | – |
|
1620
Emcor
EME
$36.7B
| $1.29M | ﹤0.01% |
26,279
+2,979
| +13% | +$142K |
|
1621
United Natural Foods
UNFI
$2.9B
| $1.28M | ﹤0.01% |
27,330
+5,000
| +22% | +$192K |
|
|
TRVN
1622
DELISTED
Trevena, Inc.
TRVN
| $1.27M | ﹤0.01% |
323
+296
| +1,096% | +$1.39M |
|
1623
Axalta
AXTA
$7.93B
| $1.26M | ﹤0.01% |
47,472
+2,957
| +7% | +$83.7K |
|
|
CIM
1624
Chimera Investment
CIM
$993M
| $1.26M | ﹤0.01% |
26,701
+7,934
| +42% | +$350K |
|
|
MZTI
1625
The Marzetti Company
MZTI
$3.18B
| $1.26M | ﹤0.01% |
9,850
+100
| +1% | +$11.9K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.